National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Breast Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2240) > Neoplasms (581) > Neoplasms by Site (431) >

Breast Neoplasms (71)

Narrow:

Breast Neoplasms, Male (3)
Carcinoma, Ductal, Breast (1)

1-20 of 71   Next >
1.   Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2–negative (or unknown) advanced breast cancer: American Society of Clinical Oncology clinical practice guideline.2014 Oct 10. NGC:010558 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
2.   Optimal systemic therapy for early female breast cancer. 2014 Sep 30. NGC:010700 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
3.   Locoregional therapy of locally advanced breast cancer (LABC). 2014 Sep 29. NGC:010699 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
4.   (1) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer. (2) Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. 2002 Aug 1 (revised 2010 Aug 10; addendum released 2014 Jul 20). NGC:010524 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
5.   Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline. 2014 July 1. NGC:010494 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
6.   Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. 2014 July 1. NGC:010495 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
7.   Society of Surgical Oncology–American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. 2014 Mar 1. NGC:010420 American Society for Radiation Oncology - Professional Association; Society of Surgical Oncology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
8.   Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Feb 18). NGC:010191 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
9.   ACR Appropriateness Criteria® ductal carcinoma in situ. 1996 (revised 2014). NGC:010674 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
10.   ACR Appropriateness Criteria® stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. 1996 (revised 2014). NGC:010443 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
11.   WHO position paper on mammography screening. 2014. NGC:010705 World Health Organization - International Agency. View all guidelines by the developer(s) Compare Selected
12.   Comparison of Oncotype DX with multi-gene profiling assays (e.g., MammaPrint, PAM50) and other tests (e.g., Adjuvant! Online, Ki-67 and IHC4) in early-stage breast cancer. 2013 Nov 20. NGC:010222 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
13.   Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat. 2013 Sep. NGC:010539 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
14.   Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. 2002 Jul (revised 2013 Nov 19). NGC:010056 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)  Compare Selected
15.   Treatment of primary breast cancer. A national clinical guideline. 1998 Oct (revised 2013 Sep). NGC:010022 Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
16.   Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. 1999 (revised 2013 Aug). NGC:009980 American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s)  Compare Selected
17.   Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy. 2013 Aug. NGC:010011 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
18.   Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer. 2013 Aug. NGC:010541 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
19.   Common breast problems. 2007 Oct (revised 2013 Jun). NGC:009958 University of Michigan Health System - Academic Institution. View all guidelines by the developer(s) Compare Selected
20.   Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. 2004 May (revised 2013 Jun). NGC:009952 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)